ACM
UTMD icon

Aquatic Capital Management’s Utah Medical Products UTMD Stock Holding History

Aquatic Capital Management’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-82
Closed -$5.04K – 1652
2024
Q4 		$5.04K Buy
+82
New +$5.3K ﹤0.01% 1264

Other funds holding UTMD

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $155M AUM 35.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Aquatic Capital Management's UTMD Position: Q1 2025 in Review

Aquatic Capital Management sold out of Utah Medical Products (UTMD) in Q1 2025, closing a stake of 82 shares — an estimated $5.04K sold.

Aquatic Capital Management first reported a position in UTMD in Q4 2024 and held it in 1 quarter. The position peaked at $5.04K in Q4 2024. 109 funds tracked by Wall St. Rank hold UTMD as of Q1 2025.

  • Aquatic Capital Management reported no remaining Utah Medical Products position as of Q1 2025 after selling out during the quarter.
  • Aquatic Capital Management sold 82 Utah Medical Products shares in Q1 2025, an estimated $5.04K.
  • Aquatic Capital Management first reported a position in Utah Medical Products in Q4 2024 and held it in 1 quarter.
  • Aquatic Capital Management's Utah Medical Products position peaked at $5.04K in Q4 2024.
  • 109 funds tracked by Wall St. Rank held Utah Medical Products as of Q1 2025.

Based on Aquatic Capital Management's 13F filing for Q1 2025, filed 15 May 2025.